Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2016

View Archived Issues

Novel neuroprotective agent shows potential for autism spectrum disorders

Phase II trial explores use of glembatumumab vedotin in recurrent or refractory osteosarcoma

BMS initiates phase II trial of BMS-986142 in patients with rheumatoid arthritis

Bellicum Pharmaceuticals' BPX-501 granted FDA orphan drug designation

Sanofi Pasteur announces first vaccinations with Dengvaxia in Philippines

FDA grants breakthrough therapy designation for oliceridine

PeptiDream and JCR Pharmaceuticals sign joint research agreement

Endo and BioDelivery announce launch of Belbuca buccal film for chronic pain management

OBI Pharma reports topline results for OBI-822/821 in patients with metastatic breast cancer

Formula and Rockland to develop a novel immunotherapy cancer pipeline

Boehringer Ingelheim Pharma discloses neutrophil elastase inhibitors

Nuevolution announces Brd4 inhibitors

Janssen Pharmaceutica patents mGlu2 receptor negative allosteric modulators

Rockwell files IND to study Triferic for iron-refractory iron-deficiency anemia

Capricor initiates phase I/II trial of CAP-1002 in DMD-related cardiomyopathy

Russian Ministry of Health accepts Pharmstandard's filing for tivozanib in RCC

Unilife and Amgen establish strategic collaboration for injectable drug delivery systems

FDA approves revised product label for Epicel

FDA lifts clinical hold on Aeolus's AEOL-10150 in acute radiation syndrome

Phase II results for armodafinil for fatigue in patients with gliomas undergoing radiotherapy

Breast Cancer Research Foundation launches collaborative breast cancer funding model

Seattle Genetics starts phase I/II trial of vadastuximab talirine in MDS

Axxam and NEOMED Institute to develop FFA4 receptor agonists for metabolic disorders

Myriad Genetics test chosen to evaluate response in phase I/II trial of niraparib and pembrolizumab

EUROIMMUN Zika virus tests launched in U.S. for research use

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...